Merrimack Pharmaceuticals Inc. appointed Richard Peters as its president and CEO, effective Feb. 6.

Peters will also be appointed a director on the same day. The appointee currently serves as senior vice president and head of global rare diseases at Sanofi Genzyme, a Sanofi subsidiary.

Merrimack's interim president and CEO, Gary Crocker, will continue to serve as the chairman of the board.